Evaluation of efficacy and tolerability of switching to ziprasidone from other antipsychotic medications
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2015
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 03 May 2008 Status changed from in progress to completed.
- 22 Oct 2007 The expected completion date for this trial is now 1 Dec 2008.
- 17 Apr 2007 New trial record.